Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received twinrix 6 months ago and skipped the 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly male patient who received HAB (Twinrix adult) for prophylaxis. Previously administered products included Twinrix adult (The patient received 1st dose on 05-SEP-2024 with batch number 4DS4N and expiry date 25-SEP-2026). On an unknown date, the patient did not receive the 2nd dose of Twinrix adult. On an unknown date, an unknown time after receiving Twinrix adult, the patient experienced incomplete course of vaccination (Verbatim: received twinrix 6 months ago and skipped the 2nd dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-FEB-2025 The pharmacist called and reported a question regarding the Twinrix vaccine. The reporter had a patient who got his 1st dose in September and knew that Twinrix was 0,1 and 6 months. However after 6 months, the patient wanted to have the Second dose and in this case the reporter asked if they should give him 2 more doses or just give 1 dose. The reporter consented to follow up. The pharmacist stated that it was a couple of husband and wife that received twinrix 6 months ago and skipped the 2nd dose. Twinrix Second late dose. VAERS details provided corresponding to the 1st dose and the case is an incomplete course of vaccination. Till the time of reporting, the patient did not receive 2nd dose of Twinrix vaccine, which led to incomplete course of vaccination.; Sender's Comments: US-GSK-US2025023093:Same reporter different patient